Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Private Advisor Group LLC

Private Advisor Group LLC cut its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 16.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,759 shares of the company’s stock after selling 557 shares during the period. Private Advisor Group LLC’s holdings in Prestige Consumer Healthcare were worth $237,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of PBH. Kayne Anderson Rudnick Investment Management LLC acquired a new stake in Prestige Consumer Healthcare in the 4th quarter valued at about $84,932,000. Raymond James Financial Inc. purchased a new stake in shares of Prestige Consumer Healthcare in the fourth quarter valued at about $42,593,000. Norges Bank acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter valued at approximately $40,009,000. Bessemer Group Inc. increased its stake in shares of Prestige Consumer Healthcare by 10,053.1% during the 4th quarter. Bessemer Group Inc. now owns 295,050 shares of the company’s stock worth $23,041,000 after purchasing an additional 292,144 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its position in shares of Prestige Consumer Healthcare by 1,073.3% during the 4th quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company’s stock worth $15,923,000 after purchasing an additional 186,524 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Down 0.3%

Shares of NYSE PBH opened at $73.73 on Friday. The firm has a market cap of $3.64 billion, a P/E ratio of 17.19, a price-to-earnings-growth ratio of 2.22 and a beta of 0.43. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20. Prestige Consumer Healthcare Inc. has a 1 year low of $64.94 and a 1 year high of $90.04. The firm’s 50 day moving average price is $80.65 and its 200 day moving average price is $82.27.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.02. The business had revenue of $296.52 million for the quarter, compared to analysts’ expectations of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The business’s revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.02 earnings per share. As a group, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have commented on PBH shares. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a “hold” rating in a report on Thursday, May 8th. Wall Street Zen upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.